ONTOLOGY REPORT - ANNOTATIONS
| Term: | leukotriene C4 |
|
| Accession: | CHEBI:16978
|
browse the term
|
| Definition: | A leukotriene that has formula C30H47N3O9S. |
| Synonyms: | exact_synonym: | L-gamma-glutamyl-S-[(1R,2E,4E,6Z,9Z)-1-[(1S)-4-carboxy-1-hydroxybutyl]pentadeca-2,4,6,9-tetraen-1-yl]-L-cysteinylglycine |
| | related_synonym: | (R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-Carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-N-L-gamma-glutamyl-L-cysteinyl)glycine; 5S,6R-Ltc(sub 4); 5S-hydroxy,6R-(S-glutathionyl),7E,9E,11Z,14Z-eicosatetraenoic acid; C30H47N3O9S; CCCCC\\C=C/C\\C=C/C=C/C=C/[C@@H](SC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)[C@@H](O)CCCC(O)=O; InChI=1S/C30H47N3O9S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-25(24(34)15-14-17-27(36)37)43-21-23(29(40)32-20-28(38)39)33-26(35)19-18-22(31)30(41)42/h6-7,9-13,16,22-25,34H,2-5,8,14-15,17-21,31H2,1H3,(H,32,40)(H,33,35)(H,36,37)(H,38,39)(H,41,42)/b7-6-,10-9-,12-11+,16-13+/t22-,23-,24-,25+/m0/s1; InChIKey=GWNVDXQDILPJIG-NXOLIXFESA-N; LTC (sub 4); LTC4 |
| | alt_id: | CHEBI:14504; CHEBI:25025; CHEBI:6422 |
| | xref_casrn: | 72025-60-6 |
| | xref: | ChEMBL:555236 "ChEMBL COMPOUND"; ChemIDplus:72025-60-6 "CAS Registry Number"; KEGG COMPOUND:72025-60-6 "CAS Registry Number"; KEGG COMPOUND:C02166 "KEGG COMPOUND"; LIPID MAPS:LMFA03020003 "LIPID MAPS instance" |
| | xref_mesh: | MESH:D017997 |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:57973 |
|
|
leukotriene C4
|
| G |
Abca8b |
ATP-binding cassette, sub-family A (ABC1), member 8b |
|
affects transport |
ISO |
11 |
109,794,720 |
109,857,130 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
affects transport |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
affects binding |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
affects transport |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
affects transport |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
increases transport |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
affects transport |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
affects transport |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
affects transport |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
affects transport |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
affects transport |
ISO |
19 |
43,856,798 |
43,912,708 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
|
affects transport |
ISO |
7 |
53,231,750 |
53,285,656 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
6 |
116,360,089 |
116,411,196 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
6 |
116,360,089 |
116,411,196 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
EXP |
6 |
116,360,089 |
116,411,196 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
6 |
116,360,089 |
116,411,196 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
multiple interactions |
ISO |
5 |
150,076,634 |
150,099,623 |
RGD:6480464 |
CTD |
| G |
Ambp |
alpha 1 microglobulin/bikunin |
|
decreases secretion |
ISO |
4 |
62,804,313 |
62,815,176 |
RGD:6480464 |
CTD |
| G |
Ccl12 |
chemokine (C-C motif) ligand 12 |
|
increases expression |
EXP |
11 |
81,915,347 |
81,916,901 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Clec7a |
C-type lectin domain family 7, member a |
|
multiple interactions |
ISO |
6 |
129,411,609 |
129,422,795 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
increases expression |
EXP |
5 |
91,320,271 |
91,322,147 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
affects binding |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
EXP |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
EXP |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
affects binding |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
multiple interactions |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
affects binding |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
affects binding |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
affects binding |
ISO |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
multiple interactions |
ISO |
14 |
73,428,935 |
73,448,921 |
RGD:6480464 |
CTD |
| G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
increases activity |
ISO |
14 |
73,428,935 |
73,448,921 |
RGD:6480464 |
CTD |
| G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
multiple interactions |
ISO |
14 |
73,428,935 |
73,448,921 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
EXP |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Gpr17 |
G protein-coupled receptor 17 |
|
increases activity |
EXP |
18 |
32,102,653 |
32,109,290 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
increases expression |
EXP |
11 |
53,444,825 |
53,448,204 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
increases abundance |
ISO |
11 |
53,444,825 |
53,448,204 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
multiple interactions |
ISO |
11 |
53,444,825 |
53,448,204 |
RGD:6480464 |
CTD |
| G |
Il5 |
interleukin 5 |
|
increases secretion |
ISO |
11 |
53,534,296 |
53,538,605 |
RGD:6480464 |
CTD |
| G |
Ltc4s |
leukotriene C4 synthase |
|
affects chemical synthesis |
ISO |
11 |
50,049,974 |
50,051,973 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
multiple interactions |
ISO |
6 |
138,089,058 |
138,105,273 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
EXP |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
increases expression |
ISO |
7 |
148,974,916 |
149,005,040 |
RGD:6480464 |
CTD |
| G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
multiple interactions |
ISO |
7 |
148,974,916 |
149,005,040 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Pla2g5 |
phospholipase A2, group V |
|
multiple interactions |
ISO |
4 |
138,355,162 |
138,419,384 |
RGD:6480464 |
CTD |
| G |
Pla2g5 |
phospholipase A2, group V |
|
multiple interactions |
EXP |
4 |
138,355,162 |
138,419,384 |
RGD:6480464 |
CTD |
| G |
Ralbp1 |
ralA binding protein 1 |
|
multiple interactions |
ISO |
17 |
66,197,755 |
66,217,171 |
RGD:6480464 |
CTD |
| G |
Ralbp1 |
ralA binding protein 1 |
|
affects transport |
ISO |
17 |
66,197,755 |
66,217,171 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin, platelet |
|
increases expression |
ISO |
1 |
166,045,509 |
166,079,876 |
RGD:6480464 |
CTD |
| G |
Syk |
spleen tyrosine kinase |
|
multiple interactions |
ISO |
13 |
52,692,251 |
52,744,161 |
RGD:6480464 |
CTD |
Term paths to the root
|